1. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer
   Alexander W. Pohlman et al, 2022, Oncotarget CrossRef
2. Mechanism and recent updates on insulin-related disorders
   Shashank Kumar et al, 2023, World Journal of Clinical Cases CrossRef
3. Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma
   Zhenglan Zhong et al, 2022, Journal of Healthcare Engineering CrossRef
4. Different Roles of the Insulin-like Growth Factor (IGF) Axis in Non-small Cell Lung Cancer
   Lixia Huang et al, 2022, Current Pharmaceutical Design CrossRef
5. Varying severity COVID-19 effects on the blood indicators of insulin-like growth factors family in patients with nonsmall cell lung cancer
   O. I. Kit et al, 2023, South Russian Journal of Cancer CrossRef
6. Nitrogen Metabolism Disorder Accelerates Occurrence and Development of Lung Adenocarcinoma: A Bioinformatic Analysis and In Vitro Experiments
   Zexin Zhang et al, 2022, Frontiers in Oncology CrossRef
7. Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma
   Yunliang Tang et al, 2021, Aging CrossRef
8. Insulin-like growth factor binding protein 5: Diverse roles in cancer
   Jennifer A. Waters et al, 2022, Frontiers in Oncology CrossRef
9. Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma
   Jun Chen et al, 2022, Frontiers in Oncology CrossRef